No results for ‘’
Vivo Bio Tech Ltd
₹24.03
(0.33%)
Wed, 24 Jun 2026, 09:45 pm
Distribution Services
Medical Distributors
24.5KVivo Bio Tech EV/EBITDA Ratio
| Particulars | 2011 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Price to earnings ratio | 203.62 | 11.33 | 25.51 | 10.80 | 28.31 | 7.13 |
| Price to book ratio | 29.27 | 1.51 | 1.20 | 0.55 | 1.17 | 0.75 |
| Price to sales ratio | 11.54 | 1.24 | 1.09 | 0.55 | 1.57 | 1.11 |
| Price to cash flow ratio | 30.87 | 4.54 | 4.06 | 3.35 | 7.71 | 8.17 |
| Enterprise value | 164Cr | 94.18Cr | 122Cr | 89.63Cr | 143Cr | 105Cr |
| Enterprise value to EBITDA ratio | 31.04 | 5.30 | 7.53 | 4.10 | 6.73 | 5.09 |
| Debt to equity ratio | 4.66 | 0.73 | 1.43 | 1.20 | 1.34 | 0.69 |
| Return on equity % | 0 | 0 | 4.91 | 5.35 | 4.75 | 11.01 |
Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio
The Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Vivo Bio Tech Ltd's valuation, profitability, and overall financial performance. Tracking the Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Vivo Bio Tech Ltd (NSE: , BSE: 511509) is currently trading at ₹24.03, with a market capitalization of ₹53.32Cr. As a leading company in the Distribution services sector and Medical distributors industry, monitoring the Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio Current Value
The current Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio stands at 5.09.
The Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 5.09
- 2023: 6.73
- 2022: 4.10
- 2021: 7.53
- 2020: 5.30
The decline in Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Vivo Bio Tech Ltd.
Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Vivo Bio Tech Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.